{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-114665","form_type":"8-K","ticker":"CRMD","cik":"0001410098","company_name":"CorMedix Inc.","filed_at":"2026-11-02T12:39:46+00:00","discovered_at":"2026-11-02T12:45:00.260525+00:00","generated_at":"2026-11-02T12:45:08.377077+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.62,"calibrated_materiality_score":0.62,"confidence":"high","headline":"CorMedix reaffirms 2026 revenue guidance of $325-345M; CMS sets Q1 2027 DefenCath Add-on at $8.32 per session","bullets":["Unaudited cash and cash equivalents of approximately $355 million as of September 30, 2026; full Q3 results to be discussed on a November 12, 2026 call.","Reaffirmed August 2026 full-year 2026 total revenue guidance of $325 million to $345 million.","CMS's October 28, 2026 ESRD PPS final rule set the Q1 2027 DefenCath post-TDAPA Add-on at $8.32 per dialysis session, 3.5x the current $2.37 rate.","CorMedix expects the Add-on to decline in Q2 2027 versus Q1, then rise in Q3 and/or Q4, with the full-year 2027 average above 2x the current $2.37.","Company said it provided no utilization or pricing data to any large dialysis organization; third-party 2027 Add-on projections are not CorMedix guidance."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-114665","json":"https://secwatch.observer/filing/0001213900-26-114665.json","markdown":"https://secwatch.observer/filing/0001213900-26-114665.md","text":"https://secwatch.observer/filing/0001213900-26-114665.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1410098/000121390026114665/0001213900-26-114665-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1410098/000121390026114665/ea0310445-8k_cormedix.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-02T12:45:08.377077+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}